Your session is about to expire
← Back to Search
Antibody Therapy
Convalescent Plasma for COVID-19
Phase 2
Waitlist Available
Led By Michele L Donato, MD
Research Sponsored by Hackensack Meridian Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights
Study Summary
This trial will test if convalescent plasma can help treat people hospitalized with COVID-19 infection.
Eligible Conditions
- COVID-19
- Coronavirus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Participants Hospitalized for COVID-19 But Not Intubated
Primary Objective for Patients With COVID-19 Already Intubated
Secondary outcome measures
Duration of Hospitalization
Duration of Mechanical Ventilation
Impact of Donor Titers Level on Efficacy
+10 moreSide effects data
From 2021 Phase 3 trial • 511 Patients • NCT0435576712%
Pneumonia
4%
Infusion related reaction
2%
Dyspnea
2%
Hypoxia
1%
Fatigue
1%
Pulmonary embolism
1%
Chest pain
1%
Flank pain
1%
Migraine
1%
Dehydration
1%
Acute respiratory failure
1%
Vomiting
1%
Dizziness
100%
80%
60%
40%
20%
0%
Study treatment Arm
Convalescent Plasma
Placebo
Trial Design
1Treatment groups
Experimental Treatment
Group I: Convalescent PlasmaExperimental Treatment1 Intervention
Fresh or frozen plasma will be infused one time to patients
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Convalescent Plasma
2020
Completed Phase 3
~4590
Find a Location
Who is running the clinical trial?
Hackensack Meridian HealthLead Sponsor
131 Previous Clinical Trials
28,192 Total Patients Enrolled
7 Trials studying COVID-19
4,612 Patients Enrolled for COVID-19
Michele L Donato, MDPrincipal InvestigatorHackensack Meridian Health
1 Previous Clinical Trials
21 Total Patients Enrolled
1 Trials studying COVID-19
21 Patients Enrolled for COVID-19
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants being enrolled in this experiment at the present moment?
"This specific study, which was first made public on April 9th 2020, is not recruiting patients at this moment. However, there are 1852 other clinical trials that currently ARE actively recruiting patients."
Answered by AI
Has the FDA given permission for Convalescent Plasma to be used as a treatment?
"Given that this is a phase 2 trial, meaning there is only anecdotal evidence supporting its safety, our team at Power has given Convalescent Plasma a score of 2."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger